Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002036530 | SCV002309302 | likely benign | not provided | 2024-08-18 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003235664 | SCV003933939 | uncertain significance | not specified | 2023-05-31 | criteria provided, single submitter | clinical testing | Variant summary: OPA1 c.2063C>T (p.Pro688Leu) results in a non-conservative amino acid change located in the Dynamin-like GTPase OPA1, C-terminal domain (IPR045817) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251160 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.2063C>T in individuals affected with OPA1-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Gene |
RCV002036530 | SCV005437837 | uncertain significance | not provided | 2024-06-11 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |